EX-99.1 2 d92156dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

FOR IMMEDIATE RELEASE

Village Farms International Reports Second Quarter 2020 Financial Results – Pure Sunfarms Achieves Sixth Consecutive Profitable Quarter on 89% Sequential Increase in Retail Branded Sales Volume – Produce Business Generates Positive Adjusted EBITDA

Pure Sunfarms Remains Top Dried Cannabis Brand with the Ontario Cannabis Store and Continues to Lead in Low-Cost Greenhouse Production as it Prepares for Imminent Launch of Cannabis 2.0 Products

Vancouver, BC, August 12, 2020 – Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) (TSX: VFF) today announced its financial results for the second quarter ended June 30, 2020. All figures are in US dollars unless otherwise indicated. On June 30, 2020, Village Farms had a majority (non-controlling) interest of 58.7% of Pure Sunfarms Corp. (“Pure Sunfarms”).

The Company’s financial statements for the three and six months ended June 30, 2020, as well as the comparative period for 2019, have been prepared and presented under United States Generally Accepted Accounting Principals (“GAAP”).

Village Farms’ Financial Summary and Corporate Highlights for the Three and Six months Ended June 30, 2020

 

($US millions except per share metric)

   Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2020     2019     Change     2020      2019      Change  

Produce Sales

   $ 47.6     $ 41.3       +15   $ 79.7      $ 73.2        +9

Net Income1

   ($ 0.1   $ 3.7 2      -103   $ 4.1      $ 10.2        -60

Income Per Share1

   ($ 0.00   $ 0.08 2      -100   $ 0.07      $ 0.21        -67

Adjusted EBITDA4

   $ 2.3     $ 4.6       -50   $ 3.4      $ 6.0        -43

 

1.

Net income includes the net income contribution from Pure Sunfarms of US$0.5 million and US$8.1 million (Village Farms’ proportionate share) for the three-month periods ended June 30, 2020 and 2019, respectively and US$4.0 million and US$10.7 million (Village Farms’ proportionate share) for the six-month periods ended June 30, 2020 and 2019, respectively.

2.

Net income for the six months ended June 30, 2019 includes a one-time gain on the sale of Delta 2 greenhouse facility of $13.6 million.

3.

Net income for the six months ended June 30, 2020 includes a $4.7 million gain on receipt of Pure Sunfarms shares from Emerald Health Therapeutics as per the Settlement Agreement.

4.

Adjusted EBITDA includes the positive EBITDA contribution from Pure Sunfarms of US$1.1 million and US$9.4 million (Village Farms’ proportionate share) for the three-month periods ended June 30, 2020 and 2019, respectively and US$3.9 million and US$12.7 million (Village Farms’ proportionate share) for the six-month periods ended June 30, 2020 and 2019, respectively. Adjusted EBITDA includes the Company’s majority non-controlling interest in Pure Sunfarms and 65% interest in VFH. Adjusted EBITDA is not a recognized earnings measure and does not have a standard meaning prescribed in by GAAP. See “Non-GAAP Measures” below.

 

1


   

Executed a binding agreement to acquire 6.6% of Australia-based Altum International Pty Ltd, one of the Asia-Pacific’s leading cannabinoid platforms, with the option to increase its ownership at a future date on similar terms;

 

   

Acquired 16% of DutchCanGrow, a Netherlands-based cannabis enterprise pursuing the opportunity to become one of a limited number of licensed cannabis growers (up to a maximum of 10) when the Dutch government permits the first legal recreational cannabis market in Europe under its 10-city Experiment to Investigate Closed Cannabis Supply Chains;

 

   

Increased its ownership of Pure Sunfarms to 58.7% as of April 2, 2020; and

 

   

Extended its non-revolving term loan with Farm Credit Canada (US$29.8 million outstanding at June 30, 2020) to a maturity date of April 1, 2025 from May 1, 2021, at a lower interest rate and monthly principal payments.

Pure Sunfarms’ Financial Summary for the Three and Six Months Ended June 30, 2020 (Before Village Farms’ Proportionate Share)

 

(millions except cost per gram and % metrics)

   Three Months Ended June 30,        
     2020     2019     Change
of C$
 
     C$     US$     C$     US$        

Total Gross Sales

   $ 19.3     $ 14.0     $ 32.4     $ 24.2       -40

Total Net Sales

   $ 12.9     $ 9.4     $ 32.4     $ 24.2       -60

Retail Branded Sales (net)

   $ 8.6     $ 6.3       —         —         N/A  

Wholesale Sales

   $ 4.3     $ 3.1     $ 32.4     $ 24.2       -87

“All-in” Cost per Gram (incl. depreciation)

   $ 0.84     $ 0.61     $ 0.65     $ 0.49       -29

Gross Margin

     33     33     84     84     -61

SG&A

   $ 2.6     $ 1.9     $ 2.4     $ 1.8       +8

Net income

   $ 1.1     $ 0.8     $ 17.4     $ 13.0       -94

EBITDA

   $ 2.5     $ 1.8     $ 25.2     $ 18.9       -90

EBITDA Margin

     19     19     78     78     -76

 

(millions except cost per gram and % metrics)

   Six Months Ended June 30,        
     2020     2019     Change
of C$
 
     C$     US$     C$     US$        

Total Gross Sales

   $ 40.8     $ 29.8     $ 46.7     $ 35.0       -13

Total Net Sales

   $ 30.9     $ 22.5     $ 46.7     $ 35.0       -34

Retail Branded Sales (net)

   $ 17.1     $ 12.4       —         —         N/A  

Wholesale Sales

   $ 13.8     $ 10.1     $ 46.7     $ 35.0       -70

“All-in” Cost per Gram (incl. depreciation)

   $ 0.83     $ 0.61     $ 0.82     $ 0.62       -1

Gross Margin

     44     44     78     78     -56

SG&A

   $ 5.8     $ 4.3     $ 3.7     $ 2.8       +57

Net income5

   $ 9.6     $ 7.0     $ 23.2     $ 17.4       -59

EBITDA

   $ 9.2     $ 6.7     $ 33.8     $ 25.3       -73

EBITDA Margin

     30     30     72     72     -58

 

5.

Net income includes C$6.0 million of debt forgiveness income as an outcome of the March 2, 2020 Settlement Agreement between Pure Sunfarms, Emerald Health Therapeutics and the Company.

 

2


Pure Sunfarms’ Recent Operating Highlights

 

   

Retail branded sales volumes for the second quarter of 2020 increased 89% compared to the first quarter of 2020;

 

   

Prepared for the imminent launch of cannabis oil products and new product forms under Cannabis 2.0;

 

   

Remained the top-selling brand of dried flower products with the Ontario Cannabis Store (“OCS”) (by kilograms sold for the year-to-date ended July 31, 2020, with a market share of 13.8% and had two of the top four selling dried cannabis products (by kilograms sold)6;

 

   

Achieved record sales (by kilograms, defined as sales of Pure Sunfarms products by the provincial boards to retailers, as well as sales by the provincial boards directly to consumers via their web sites) in Ontario, Alberta and British Columbia in aggregate for the month of July;

 

   

Launched multiple new dried cannabis products, including additional large-format (28-gram) packages, two new strains, additional pre-rolls and seeds;

 

   

Launched its dried cannabis products in its fourth and fifth provincial markets (Saskatchewan and Manitoba) such that Pure Sunfarms’ products are now available in five of Canada’s six most populous provinces, which in aggregate represent more than 70% of the total Canadian population.

 

   

Received from Health Canada its cannabis cultivation sales licence based on an initial production area within its second 1.1 million square foot greenhouse facility in Delta, British Columbia (the “Delta 2 facility”), allowing it to expand capacity as needed through successive license amendments; and,

 

   

Expanded its credit facility (the “Credit Facility”) with the lending syndicate led by Bank of Montreal and including Farm Credit Canada (“FCC”) and the addition of CIBC to its full $59 million capacity with the completion of the Credit Facility’s accordion feature.

 

6.

Data cited has been calculated by Pure Sunfarms from sales information provided by OCS.

COVID-19 Update

All Village Farms’ production facilities in Texas, British Columbia, and Pure Sunfarms’ facilities in Canada remain open and operational. The Company has experienced a small number of COVID-19 illnesses at some produce facilities, however, the Company’s protocols were followed and there has been no material disruption to operations. Village Farms and Pure Sunfarms adhere to the highest health and safety standards in their operations and each has put in place heightened hygiene practices and safety protocols, including more stringent cleaning and sanitization, and are taking appropriate precautions throughout all operations as per the recommendations of health authorities. The Company will continue to enhance and evolve such practices and protocols as the situation warrants.

Management Commentary

“The second quarter continues to demonstrate the earnings capacity of Pure Sunfarms as it delivered its sixth consecutive quarter of net income and seventh consecutive quarter of positive EBITDA,” said Michael DeGiglio, CEO Village Farms. “Although retail branded sales were level compared to the first quarter on a dollar basis, retail sales volume increased 89% as Pure Sunfarms’ continued to have great success with its large-format, value offerings, which have consistently ranked among the best-selling dried cannabis products with the Ontario Cannabis Store since launch. Importantly, even with its aggressive pricing strategy a necessity in Canada to capture share from the illicit market - Pure Sunfarms generated 33% gross margin for the quarter. We look forward to a stronger back half of 2020 for Pure Sunfarms, supported by the continued sales momentum we have seen early in the third quarter, the addition of new provincial markets, the steady increase in the number of retail stores throughout the country, and the imminent launch of its first Cannabis 2.0 products and bottled oils. We have also seen a marked uptick in activity in the wholesale business recently.”

 

3


“Pure Sunfarms remains the top selling brand of dried cannabis with the Ontario Cannabis Store to date in 2020 with nearly 14% market share as its focus on providing quality products that consumers want at an attractive price continues to resonate well with consumers. We expect this value proposition to translate to the bottled oil and Cannabis 2.0 categories as these products are introduced in the weeks and months to come. Pure Sunfarms’ industry leading all-in cost of production continues to set it apart from other suppliers, enabling it to offer high-quality products at attractive prices to drive sales and grow market share in the legal market, as well as to capture share from the illicit market, while consistently generating profitability.”

“As Pure Sunfarms continues to execute on plan, and remains well positioned for strong growth as one of what we believe will be just a few large industry suppliers, we are leveraging our cannabis success in Canada, along with our three decades of experience in vertically integrated, intensive agriculture to pursue strategic, early-stage CBD and cannabis opportunities internationally. We are excited to have taken our first steps in this regard with our recently announced strategic investments with Altum International for the Asia-Pacific region and DutchCanGrow for the Netherlands, and look forward to further expanding our international reach through prudent capital allocation with outsized, long-term potential. And we do so with the prospect of the Village Farms-owned 2.6 million square foot Delta 1 greenhouse facility being available to transition to higher value products for export should Pure Sunfarms choose to not exercise its option on that facility prior to its expiry just about a year from now.”

“Our produce business had a strong second quarter, marked by nearly $6 million year-over-year improvement in adjusted EBITDA to positive $1.2 million. Our steady progress transitioning capacity displaced by cannabis to partner growers, as well as our continuing focus on cost management, combined with higher pricing due to elevated consumer demand, to generate positive adjusted EBITDA. Village Farms’ extensive organizational capabilities and experience that underly our produce position, as well as one of the largest greenhouse footprints in North America, continue to position our Company for the evolution of cannabis in the United States. We remain optimistic about the FDA providing a clearer regulatory framework around the use of CBD in products based on its recent comments, as well as the prospects for federally legalized high-THC recreational cannabis, with a head start on conversion of one of Texas greenhouses, and the ability to rapidly pursue each of these markets.”

Summary Statutory Results

(in thousands of U.S. Dollars unless otherwise indicated)

 

     For the three months
ended June 30,
     For the six months ended
June 30,
 
     2020      2019      2020      2019  

Produce sales

   $ 47,573      $ 41,329      $ 79,685      $ 73,219  

Cost of sales

     (44,044      (44,299      (75,391      (75,514

Selling, general and administrative expenses

     (3,813      (3,949      (7,734      (8,188

Stock compensation expense

     (328      (701      (857      (1,997

Interest expense

     (437      (669      (974      (1,363

Interest income

     93        211        476        347  

Foreign exchange gain (loss)

     530        243        (396      521  

Gain on settlement

     —          —          4,681        —    

Other income (expense), net

     26        282        65        152  

(Loss) gain on disposal of assets

     —          —          (6      13,564  

Loss on write-off of investment

     —          —          —          —    

(Provision for) recovery of income taxes

     (69      3,284        943        (1,152

Share of income from joint ventures

     350        7,985        3,579        10,593  

Net income

   ($ 119    $ 3,716      $ 4,071      $ 10,182  

Adjusted EBITDA (1)

   $ 2,268      $ 4,644      $ 3,364      $ 5,990  

Earnings per share – basic

   ($ 0.00    $ 0.08      $ 0.07      $ 0.21  

Earnings per share – diluted

   ($ 0.00    $ 0.07      $ 0.07      $ 0.20  

 

4


Summary Results Including Joint Ventures, on a Proportionate Basis

The following results reflect the Company’s proportionate share of the Pure Sunfarms joint venture operations, as this is the basis on which management bases its operating decisions and performance. For a reconciliation to the results in accordance with GAAP refer to the “Reconciliation of GAAP to Proportionate Results” as presented below.

(in thousands of U.S. Dollars unless otherwise indicated)

 

     For the three months
ended June 30,
     For the six months
ended June 30,
 
     2020 (2)      2019 (2)      2020      2019  

Consolidated sales

   $ 53,082      $ 56,395      $ 92,734      $ 95,013  

Cost of sales

     (47,722      (46,773      (82,746      (80,439
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross margin

     5,360        9,622        9,988        14,574  
  

 

 

    

 

 

    

 

 

    

 

 

 

Selling, general and administrative expenses

     (5,069      (5,184      (10,455      (10,034

Share-based compensation

     (328      (701      (857      (1,997

Interest expense

     (540      (900      (1,370      (1,544

Interest income

     93        211        476        347  

Foreign exchange (loss) gain

     547        228        (481      535  

Gain on settlement

     —          —          4,681        —    

Forgiveness of debt income

     (9      —          2,496        —    

Other income (expense)

     118        334        132        159  

(Loss) gain on disposal of assets

     —          —          9        13,564  
  

 

 

    

 

 

    

 

 

    

 

 

 

(Loss) income before taxes

     173        3,610        4,619        15,598  
  

 

 

    

 

 

    

 

 

    

 

 

 

Recovery of (provision for) income taxes

     (291      106        (548      (5,416
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   ($ 119    $ 3,716      $ 4,071      $ 10,182  
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted EBITDA(1)

   $ 2,268      $ 4,644      $ 3,364      $ 5,990  

Earning (loss) per share – basic

   ($ 0.00    $ 0.08      $ 0.07      $ 0.21  

Earning (loss) per share – diluted

   ($ 0.00    $ 0.07      $ 0.07      $ 0.20  

Notes:

 

(1)

Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. See “Non-GAAP Measures”. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated Adjusted EBITDA includes the Company’s majority non-controlling Pure Sunfarms and 65% interest in VFH.

(2)

The adjusted consolidated financial results have been adjusted to include the Company’s share of revenues and expenses from its Pure Sunfarms and Hemp joint ventures on a proportionate accounting basis, on which management bases its operating decisions and performance evaluation. GAAP does not allow for the inclusion of the Joint Venture on a proportionate basis. These results include additional non-GAAP measures such as EBITDA.

The adjusted results are not generally accepted measures of financial performance under GAAP. The Company’s method of calculating these financial performance measures may differ from other companies and accordingly, they may not be comparable to measures used by other companies. See “Non-GAAP measures” below for a reconciliation of these non-GAAP measures and adjusted results.

Financial Highlights

(All amounts in U.S. Dollars unless otherwise indicated.)

Cannabis

Summary of Total Pure Sunfarms for the three months ending June 30,:

 

     2020      2019  
     C$      US$      C$      US$  

Sales, Net

   $ 12,902      $ 9,386      $ 32,356      $ 24,244  

Cost of Goods

     8,594        6,266        5,293        3,956  

Gross Profit

     4,308        3,120        27,063        20,288  

Selling, general and administrative expenses

     2,574        1,850        2,384        1,786  

Net Income

   $ 1,079      $ 789      $ 17,388      $ 13,019  

EBITDA

   $ 2,509      $ 1,833      $ 25,200      $ 18,893  

 

5


Summary of Pure Sunfarms, Village Farms Proportionate Share for the three months ending June 30,:

 

     2020      2019  
     C$      US$      C$      US$  

Sales, Net

   $ 7,006      $ 5,509      $ 20,111      $ 15,066  

Cost of Goods

     5,046        3,678        3,312        2,474  

Gross Profit

     1,959        1,832        16,799        12,594  

Selling, general and administrative expenses

     1,511        1,086        1,488        1,115  

Net Income

   $ 634      $ 463      $ 10,826      $ 8,105  

EBITDA

   $ 1,473      $ 1,076      $ 15,868      $ 9,449  

Summary of Total Pure Sunfarms for the six months ending June 30,:

 

     2020      2019  
     C$      US$      C$      US$  

Sales, Net

   $ 30,906      $ 22,523      $ 46,715      $ 35,045  

Cost of Goods

     17,201        12,524        10,369        7,774  

Gross Profit

     13,705        9,999        36,346        27,271  

Selling, general and administrative expenses

     5,829        4,284        3,712        2,785  

Net Income

   $ 9,632      $ 6,954      $ 23,241      $ 17,422  

EBITDA

   $ 9,235      $ 6,702      $ 33,776      $ 25,344  

Summary of Pure Sunfarms, Village Farms Proportionate Share for the six months ending June 30,:

 

     2020      2019  
     C$      US$      C$      US$  

Sales, Net

   $ 17,209      $ 12,951      $ 29,056      $ 21,794  

Cost of Goods

     9,940        7,235        6,571        4,925  

Gross Profit

     7,270        5,716        22,485        16,869  

Selling, general and administrative expenses

     3,316        2,434        2,264        1,698  

Net Income

   $ 5,533      $ 3,994      $ 14,337      $ 10,747  

EBITDA

   $ 5,125      $ 3,854      $ 16,888      $ 12,675  

For the three months ended June 30, 2020 compared to the three months ended June 30, 2019.

Sales

Net sales for the three months ended June 30, 2020 and 2019 were $9,386 and $24,244, respectively, a decrease of (61%). The decrease was a result of lower 2020 average selling price for the three months ended June 30, 2020 versus the three months ended June 30, 2019 at which time all of Pure Sunfarms’ sales were solely through the wholesale channel during a period of elevated market pricing.

Kilograms sold to provincial boards for the three months ended June 30, 2020 increased 89% over sales to provincial boards in the first quarter of 2020. Wholesale kilograms sold decreased (39%) in the second quarter of 2020 versus the first quarter of 2020. Total kilograms sold for the second quarter of 2020 were essentially unchanged from the first quarter of 2020. The net average selling price for the three months ended June 30, 2020 was lower than the net average selling price for the three months ended March 31, 2020 by (29%).

 

6


Net sales for three months ended June 30, 2020 was impacted by sales adjustments on small format and pre-roll SKUs in order to continue Pure Sunfarms market leading value priced SKUs, in part due to the success of the Pure Sunfarms large format SKUs. Additionally, an increase in the provision for returns was taken on certain strains with a single provincial board that Pure Sunfarms has agreed to accept, and which Pure Sunfarms will utilize in some of its future cannabis 2.0 products.

During the three months ended June 30, 2020, 57% of kilograms sold (flower) were to provincial boards, with the remaining 43% of kilograms sold (flower and trim) being through the wholesale channel, including nonmonetary transactions with extraction licensed producers in which Pure Sunfarms sold extraction grade dried flower and trim and purchased various forms of distillate from the same counterparties, which will be ultilized Pure Sunfarms in future cannabis 2.0 product launches.

Cost of Goods

Cost of goods sold for the three months ended June 30, 2020 and 2019 was $6,266 and $3,956, or $0.61 per kgs (CA$0.84), versus $0.49 per kgs (CA$0.62) in the second quarter of 2019. The higher cost in 2020 was primarily driven by additional packaging and logistics costs incurred for retail sales versus all sales were made to the wholesale channel in 2019.The cost per gram sold for the three months ended June 30, 2020 was lower than the cost per gram in the first quarter of 2020, by 5%, even with the significant increase in retail sales quarter on quarter, which is a reflection of the increase in large format SKUs in the product mix and a lower cost of cultivation.

Gross Margin

Gross margin for the three months ended June 30, 2020 was 33% versus 84% for the three months ended June 30, 2019. The reduction is due to the lower price environment in 2020 versus 2019 and the change in mix to retail sales in 2020 versus all wholesale sales in the second quarter of 2019. Retail sales involve incremental packaging and logistics costs over bulk wholesale sales.

The gross margin of 33% in the second quarter is lower than the 52% in the first quarter of 2020 due to a lower pricing environment in the second quarter of 2020 in both the retail and wholesale channels, as well as the price adjustments and an increase in the return provision in the second quarter of 2020.

Selling, General and Administrative Expense

Selling, general and administrative expenses for the three months ended June 30, 2020 and 2019 was $1,850 and $1,786, respectively, an increase of 3.6%. The increase is primarily due to regulatory fees for Health Canada and staffing. The second quarter 2020 selling, general and administrative expenses decreased by (24%) versus the first quarter of 2020 due to a reduction in branding and marketing costs as a result of decreased retail marketing activity as a result of COVID-19 as well as a one-off wage subsidy that was recognized in the second quarter as a result of a federal COVID-19 program.

Net Income

Net income for the three months ended June 30, 2020 and 2019 was $789 and $13,019, respectively, a decrease of (93.9%). The decrease was primarily due to the decrease in sales driven by lower market pricing year on year.

 

7


Adjusted EBITDA

Adjusted earnings before interest expense, income taxes, depreciation and amortization (“EBITDA”) for the three months ended June 30, 2020 and 2019 was $1,833 and $18,893, respectively. The decrease is primarily due to lower selling prices for the three months ended June 30, 2020 compared to the same prior year period.

Produce

For the three months ended June 30, 2020 compared to the three months ended June 30, 2019.

Sales for the three months ended June 30, 2020 increased $6,244, or 15.1%, to $47,573 compared to $41,329 for the three months ended June 30, 2019. The increase in sales is primarily due to an increase in supply partner revenues, partially offset by a decrease in our own production revenues. The decrease in our own production revenues is primarily due to a decrease of (26%) in our product volume and an increase in average selling price of 35%. The decrease in our own production volume is primarily due to the closure of the Delta 2 facility that was contributed to Pure Sunfarms as well as ongoing plant disease pressure at our Texas facilities.

Cost of sales for the three months ended June 30, 2020 decreased ($255) to $44,044 from $44,299 for the three months ended June 30, 2019, due to a decrease in pounds sold from the Texas facilities, the closure of the Delta 2 facility and a decrease in freight expense, mostly offset by an increase in the 2020 supply partner costs. The decrease in freight and cost from Texas facilities is due to a decrease in our own production volume.

Adjusted produce EBITDA for the three months ended June 30, 2020 increased by $5,907 to $1,234 from ($4,673) for the three months ended June 30, 2019. The increase is primarily the result of an increase in the Company’s gross profit, due to an increase in the average selling price of the Company’s own and supply partner products of 29%.

Non-GAAP Measures

References in this news release to “Adjusted EBITDA” are to earnings (including the equity in earnings of the Joint Ventures) before interest, taxes, depreciation and amortization (“EBITDA”), as further adjusted to exclude foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, stock compensation, and gains and losses on asset sales. Adjusted EBITDA is a cash flow measure that is not recognized under GAAP and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that Adjusted EBITDA should not be construed as an alternative to net income or loss determined in accordance with GAAP as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that Adjusted EBITDA is an important measure in evaluating the historical performance of the Company.

We also present Adjusted EBITDA, earnings per share and diluted earnings per share on a proportionate segment basis. Each of the components of Adjusted EBITDA, on a proportionate segment basis, are presented in the table Reconciliation of GAAP to Proportionate Results. We believe that the ability of investors to assess our overall performance may be improved by the disclosure of proportionate segment Adjusted EBITDA, earnings per share and diluted earnings per share.

The following table reflects a reconciliation of net income to Adjusted EBITDA, as presented by the Company:

 

8


(in thousands of U.S. dollars)    For the three months
ended June 30,
     For the six months ended
June 30,
 
     2020      2019      2020      2019  

Net income (loss)

   ($ 119    $ 3,716      $ 4,071      $ 10,182  

Add:

           

Amortization

     1,491        1,964        3,021        3,804  

Foreign currency exchange loss (gain)

     (530      (243      396        (521

Interest expense, net

     344        458        498        1,016  

Income taxes (recovery) / provision

     69        (3,284      (943      1,152  

Stock based compensation

     328        701        857        1,997  

Interest expense for JVs

     103        230        396        230  

Amortization for JVs

     377        415        678        711  

Foreign currency exchange loss (gain) for JVs

     (17      16        85        (13

Income taxes provision from JVs

     222        3,178        1,491        4,264  

Gain on disposal of assets

     —          —          (9      (13,564

Gain on settlement

     —          —          (4,681      —    

JV gain on settlement

     —          —          (2,496      —    

True economic benefit Pure Sunfarms(3)

     —          (2,507      —          (3,268
  

 

 

    

 

 

    

 

 

    

 

 

 

Adjusted EBITDA

   $ 2,268      $ 4,644      $ 3,364      $ 5,990  

Adjusted EBITDA for JVs (See table below)

   $ 1,034      $ 9,317      $ 3,717      $ 12,520  

Adjusted EBITDA excluding JVs(produce)

   $ 1,234      ($ 4,673    ($ 353    ($ 6,530

 

(3)

The GAAP treatment of the Company’s equity earnings of its Joint Venture (“Pure Sunfarms”) is different than treatment under IFRS. Under GAAP, the Emerald shares held in escrow and not fully paid for by Emerald are not considered issued pursuant to the GAAP concept of ‘hypothetical liquidation’. As a result, under GAAP, the Company’s ownership percentage for the three months and six months ended June 30, 2019 was higher than its economic interest of 50%. Accordingly, for those periods with a higher deemed ownership percentage, the Company received a higher allocation of profits and losses during the periods in which there were outstanding escrow shares not paid for by Emerald. The effective profit and loss allocation on a weighted-average basis for the three months and six months ended June 30, 2019 was 62.2% for both periods.

The following tables are a reconciliation of the GAAP results to the proportionate results (which include the Company’s proportionate share of the Pure Sunfarms operations):

 

     For the three months ended June 30, 2020  
     Produce      Pure
Sunfarms(4)
     Hemp(4)      Total  

Consolidated sales

   $ 47,573      $ 5,509      $ —        $ 53,082  

Cost of sales

     (44,044      (3,678      —          (47,722

Gross margin

     3,529        1,831        —          5,360  

Selling, general and administrative expenses

     (3,813      (1,086      (170      (5,069

Share-based compensation

     (328                    (328

Interest expense

     (437      (77      (26      (540

Interest income

     93                      93  

Foreign exchange loss

     530        17               547  

Gain on settlement

                           

JV gain on settlement

            (9             (9

Other income (expense)

     26        9        82        1184  

(Loss) gain on disposal of assets

            —                 —    

(Loss) income before taxes

     (400      686        (113      (173

Recovery of (provision for) income taxes

     (69      (222             (291

Net income (loss)

     (469      463        (113      (119

Adjusted EBITDA

     1,234        1,076        (42      2,268  

Earning (loss) per share – basic

   ($ 0.01    $ 0.01      $ (0.00    ($ 0.00

Earning (loss) per share – diluted

   ($ 0.01    $ 0.01      $ (0.00    ($ 0.00

 

9


     For the three months ended June 30, 2019  
     Produce      Pure
Sunfarms(4)
     Hemp(4)      Total  

Sales

   $ 41,329      $ 15,066      $ —        $ 56,395  

Cost of sales

     (44,299      (2,474             (46,773

Gross margin

     (2,970      12,592               9,622  

Selling, general and administrative expenses

     (3,949      (1,115      (120      (5,184

Share-based compensation

     (701             —          (701

Interest expense

     (669      (231      —          (900

Interest income

     211        —          —          211  

Foreign exchange gain

     243        (15      —          228  

Gain on settlement

     —          —          —          —    

JV gain on settlement

     —          —          —          —    

Other income (expense)

     282        52        —          334  

Gain on disposal of assets

                          —    

(Loss) income before taxes

     (7,553      11,283        (120      3,610  

Recovery of (provision for) income taxes

     3,284        (3,178      —          106  

Net income (loss)

   ($ 4,269    $ 8,105      ($ 120    $ 3,716  

Adjusted EBITDA(5)

   ($ 4,673    $ 9,449      ($ 132    $ 4,644  

Earnings (loss) per share – basic

   ($ 0.09    $ 0.17      $ (0.00    $ 0.08  

Earnings (loss) per share – diluted

   ($ 0.09    $ 0.16      $ (0.00    $ 0.07  

Notes:

 

(4)

The adjusted consolidated financial results have been adjusted to include the Company’s share of revenues and expenses from its Pure Sunfarms and Hemp joint ventures on a proportionate accounting basis, on which management bases its operating decisions and performance evaluation. GAAP does not allow for the inclusion of the Joint Venture on a proportionate basis. These results include additional non-GAAP measures such as EBITDA.

 

     For the six months ended June 30, 2020  
     Produce      Pure
Sunfarms(4)
     Hemp(4)      Total  

Consolidated sales

   $ 79,685      $ 12,951      $ 98      $ 92,734  

Cost of sales

     (75,391      (7,235      (120      (82,746

Gross margin

     4,294        5,717        (22      9,988  

Selling, general and administrative expenses

     (7,734      (2,434      (287      (10,455

Share-based compensation

     (857      —          —          (857

Interest expense

     (974      (198      (198      (1,370

Interest income

     476        —          —          476  

Foreign exchange loss

     (396      (85      —          (481

Gain on settlement

     4,681        —          —          4,681  

JV gain on settlement

     —          2,496        —          2,496  

Other income (expense)

     65        (15      82        132  

(Loss) gain on disposal of assets

     (6      5        10        9  

(Loss) income before taxes

     (451      5,485        (415      4,619  

Recovery of (provision for) income taxes

     943        (1,491      —          (548

Net income (loss)

   $ 492        3,994        (415      4,071  

Adjusted EBITDA

   ($ 353      3,854        (137      3,364  

Earning (loss) per share – basic

   $ 0.01      $ 0.07      ($ 0.01    $ 0.07  

Earning (loss) per share – diluted

   $ 0.01      $ 0.07      ($ 0.01    $ 0.07  

 

10


     For the six months ended June 30, 2019  
     Produce      Pure
Sunfarms(4)
     Hemp(4)      Total  

Sales

   $ 73,219      $ 21,794      $ —        $ 95,013  

Cost of sales

     (75,514      (4,925             (80,439

Gross margin

     (2,295      16,869               14,574  

Selling, general and administrative expenses

     (8,188      (1,698      (154      (10,040

Share-based compensation

     (1,997             —          (1,997

Interest expense

     (1,363      (181      —          (1,544

Interest income

     347        —          —          347  

Foreign exchange gain

     521        14        —          535  

Gain on settlement

     —          —          —          —    

JV gain on settlement

     —          —          —          —    

Other income (expense)

     152        7        —          159  

Gain on disposal of assets

     13,564                      13,564  

Income (loss) before taxes

     741        15,011        (154      15,555  

Recovery of (provision for) income taxes

     (1,152      (4,264      —          (5,416

Net income (loss)

   ($ 411    $ 10,747      ($ 154    $ 10,182  

Adjusted EBITDA(5)

   ($ 6,530    $ 12,675      ($ 155    $ 5,990  

Earnings (loss) per share – basic

   ($ 0.01    $ 0.22      ($ 0.00    $ 0.21  

Earnings (loss) per share – diluted

   ($ 0.01    $ 0.21      ($ 0.00    $ 0.20  

 

Breakout of JV’s Adjusted EBITDA

(in thousands of U.S. dollars)

   For the three months
ended June 30,
     For the six months
ended June 31,
 
     2020      2019      2020      2019  

Pure Sunfarms Adjusted EBITDA

   $ 1,076      $ 9,449      $ 3,854      $ 12,675  

VFH Adjusted EBITDA

     (42      (132      (137      (155
  

 

 

    

 

 

    

 

 

    

 

 

 

Total JV’s Adjusted EBITDA

   $ 1,034      $ 9,417      $ 3,717      $ 12,520  
  

 

 

    

 

 

    

 

 

    

 

 

 

This press release is intended to be read in conjunction with the Company’s Consolidated Financial Statements (“Financial Statements”) and Management’s Discussion & Analysis (“MD&A”) for the three and six month periods ended June 30, 2020 in the Company Form 10-Q, which will be filed on (www.sec.gov/edgar.shtml) and SEDAR (www.sedar.com) and will be available at www.villagefarms.com.

Conference Call

Village Farms’ management team will host a conference call tomorrow, Thursday, August 13, 2020, at 8:30 a.m. ET to discuss its financial results. Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at: https://bit.ly/3i7Dvpu.

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 4688349 followed by the pound key. The telephone replay will be available until Thursday, August 20, 2020 at midnight (ET). The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls.

 

11


About Village Farms International, Inc.

Village Farms is one of the largest and longest-operating vertically integrated greenhouse growers in North America. Village Farms produces and distributes fresh, premium-quality produce year-round to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in Canada and the U.S., as well as from its partner greenhouses in Canada and Mexico. The Company is leveraging its 30 years of experience as a large-scale, low-cost vertically integrated grower for the rapidly emerging global cannabis and CBD opportunities. In Canada, British-Columbia-based Pure Sunfarms (majority-owned by Village Farms) is one of the single largest cannabis operations in the world and one of the best-selling brands in the country. In the U.S., subject to compliance with all applicable U.S. federal and state laws, the Company is pursuing a strategy become a leading developer and supplier of branded and white-labeled CBD products targeting “big box” and other major retailers and consumer packaged goods companies, and with one the largest greenhouse operations in country, is well positioned for the potential federal legalization of high-THC cannabis. Internationally, Village Farms is strategically targeting nascent, legal cannabis and CBD opportunities with significant long-term potential.

Cautionary Statement Regarding Forward-Looking Information

This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and is subject to the safe harbor created by those sections. This press release also contains “forward-looking information” within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as “forward-looking statements”. Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “try”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this press release are subject to risks that may include, but are not limited to: our limited operating history, including that of our Pure Sunfarms Corp. joint venture for the production of cannabis in Canada (our “Joint Venture”) and our start-up operations of growing hemp in the United States; the legal status of our Joint Venture; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp and agricultural businesses; the ability of our Joint Venture to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., our Joint Venture’s ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for our Joint Venture; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured

 

12


losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this press release. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

 

13


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars, except share data)

(Unaudited)

 

     June 30, 2020     December 31, 2019  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 9,568     $ 11,989  

Trade receivables

     13,912       8,997  

Inventories

     13,123       15,918  

Amounts due from joint ventures

     10,661       15,418  

Other receivables

     589       342  

Income tax receivable

     841       713  

Prepaid expenses and deposits

     1,136       1,259  
  

 

 

   

 

 

 

Total current assets

     49,830       54,636  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment

     60,498       63,158  

Investment in joint ventures

     61,721       41,334  

Notes receivable - joint ventures

     10,841       10,865  

Deferred tax asset

     8,885       7,999  

Right-of-use assets

     4,387       3,582  

Other assets

     1,779       1,834  
  

 

 

   

 

 

 

Total assets

   $ 197,941     $ 183,408  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Line of credit

   $ 4,000     $ 2,000  

Trade payables

     9,849       12,653  

Current maturities of long-term debt

     2,377       3,423  

Accrued liabilities

     7,037       3,017  

Operating lease liabilities - current

     1,741       875  

Finance lease liabilities - current

     40       61  
  

 

 

   

 

 

 

Total current liabilities

     25,044       22,029  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt

     28,354       28,966  

Deferred tax liability

     1,728       1,873  

Operating lease liabilities - non-current

     2,746       2,690  

Finance lease liabilities - non-current

     16       34  

Other liabilities

     1,322       1,357  
  

 

 

   

 

 

 

Total liabilities

     59,210       56,949  
  

 

 

   

 

 

 

Commitments and contingencies

    

SHAREHOLDERS’ EQUITY

    

Common stock, no par value per share - unlimited shares authorized; 56,402,418 shares issued and outstanding at June 30, 2020 and 52,656,669 shares issued and outstanding at December 31, 2019

     105,829       98,333  

Additional paid in capital

     5,128       4,351  

Accumulated other comprehensive loss

     (547     (475

Retained earnings

     28,321       24,250  
  

 

 

   

 

 

 

Total shareholders’ equity

     138,731       126,459  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 197,941     $ 183,408  
  

 

 

   

 

 

 

 

14


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income (Loss)

(In thousands of United States dollars, except per share data, unless otherwise noted)

(Unaudited)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2020     2019     2020     2019  

Sales

   $ 47,573     $ 41,329     $ 79,685     $ 73,219  

Cost of sales

     (44,044     (44,299     (75,391     (75,514
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     3,529       (2,970     4,294       (2,295

Selling, general and administrative expenses

     (3,813     (3,949     (7,734     (8,188

Share-based compensation

     (328     (701     (857     (1,997

Interest expense

     (437     (669     (974     (1,363

Interest income

     93       211       476       347  

Foreign exchange gain (loss)

     530       243       (396     521  

Gain on settlement agreement

                 4,681        

Other income

     26       282       65       152  

(Loss) gain on disposal of assets

                 (6     13,564  
  

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before taxes and earnings from unconsolidated entities

     (400     (7,553     (451     741  

(Provision for) recovery of income taxes

     (69     3,284       943       (1,152
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss (income) from consolidated entities after income taxes

     (469     (4,269     492       (411

Equity earnings from unconsolidated entities

     350       7,985       3,579       10,593  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

   $ (119   $ 3,716     $ 4,071     $ 10,182  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic (loss) income per share

   $ (0.00   $ 0.08     $ 0.07     $ 0.21  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (loss) income per share

   $ (0.00   $ 0.07     $ 0.07     $ 0.20  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares used in the computation of net (loss) income per share (in thousands):

        

Basic

     56,339       48,825       54,636       48,322  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted

     56,339       50,712       55,756       50,159  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

   $ (119   $ 3,716     $ 4,071     $ 10,182  

Other comprehensive (loss) income:

        

Foreign currency translation adjustment

     55       36       (72     80  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss) income

   $ (64   $ 3,752     $ 3,999     $ 10,262  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

15


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

(In thousands of United States dollars)

(Unaudited)

 

     Six Months Ended June 30,  
     2020     2019  

Cash flows used in operating activities:

    

Net income

   $ 4,071     $ 10,182  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     3,021       3,766  

Amortization of deferred charges

     38       38  

Share of income from joint ventures

     (3,579     (10,593

Interest expense

     974       1,363  

Interest income

     (476     (347

Interest paid on long-term debt

     (1,018     (1,063

Gain on settlement agreement

     (4,681      

Loss (gain) on disposal of assets

     6       (13,564

Non-cash lease expense

     (627     (513

Interest paid on finance leases

     (2     (4

Share-based compensation

     857       1,997  

Deferred income taxes

     (400     1,144  

Changes in non-cash working capital items

     3,961       (1,843
  

 

 

   

 

 

 

Net cash provided by (used) in operating activities

     2,145       (9,437
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Purchases of property, plant and equipment, net of rebate

     (452     (730

Advances to joint ventures

     (125     (5,806

Proceeds from sale of asset

           60  

Investment in joint ventures

     (11,713     (13
  

 

 

   

 

 

 

Net cash used in investing activities

     (12,290     (6,489
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from borrowings

     3,000       3,000  

Repayments on borrowings

     (2,652     (1,709

Proceeds from issuance of common stock

     7,957       13,928  

Issuance costs

     (663      

Proceeds from exercise of stock options

     122       75  

Payments on capital lease obligations

     (39     (48

Proceeds from exercise of warrants

           466  
  

 

 

   

 

 

 

Net cash provided by financing activities

     7,725       15,712  
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (1      
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (2,421     (214

Cash and cash equivalents, beginning of period

     11,989       11,920  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 9,568     $ 11,706  
  

 

 

   

 

 

 

SOURCE Village Farms International, Inc.

For further information: Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

 

16